Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB, Jørgensen JO.

Diabetes. 2013 Apr;62(4):1186-95. doi: 10.2337/db12-0975. Epub 2012 Nov 28.

PMID:
23193181
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.

Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW, Klein S.

Cell Metab. 2012 Nov 7;16(5):658-64. doi: 10.1016/j.cmet.2012.09.015. Epub 2012 Oct 25.

PMID:
23102619
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.

Syvertsen C, Halse J, Høivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M, Gudmundsen O.

Int J Obes (Lond). 2007 Jul;31(7):1148-54. Epub 2006 Oct 10.

PMID:
17031391
[PubMed - indexed for MEDLINE]
4.

Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men.

Risérus U, Vessby B, Arnlöv J, Basu S.

Am J Clin Nutr. 2004 Aug;80(2):279-83.

PMID:
15277146
[PubMed - indexed for MEDLINE]
Free Article
5.

Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.

Pasarica M, Zachwieja JJ, Dejonge L, Redman S, Smith SR.

J Clin Endocrinol Metab. 2007 Nov;92(11):4265-70. Epub 2007 Sep 4.

PMID:
17785361
[PubMed - indexed for MEDLINE]
6.

Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.

Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P.

Cell Metab. 2011 Nov 2;14(5):612-22. doi: 10.1016/j.cmet.2011.10.002.

PMID:
22055504
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

Svensson J, Lönn L, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjöström L, Bengtsson BA.

J Clin Endocrinol Metab. 1998 Feb;83(2):362-9.

PMID:
9467542
[PubMed - indexed for MEDLINE]
8.

Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.

Eliasson B, Gudbjörnsdottir S, Cederholm J, Liang Y, Vercruysse F, Smith U.

Int J Obes (Lond). 2007 Jul;31(7):1140-7. Epub 2007 Feb 13.

PMID:
17264849
[PubMed - indexed for MEDLINE]
9.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
[PubMed - indexed for MEDLINE]
10.

Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.

Goh KP, Lee HY, Lau DP, Supaat W, Chan YH, Koh AF.

Int J Sport Nutr Exerc Metab. 2014 Feb;24(1):2-13. doi: 10.1123/ijsnem.2013-0045. Epub 2013 Aug 5.

PMID:
23918588
[PubMed - indexed for MEDLINE]
11.

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial.

Smith SR, De Jonge L, Volaufova J, Li Y, Xie H, Bray GA.

Metabolism. 2005 Jan;54(1):24-32.

PMID:
15562376
[PubMed - indexed for MEDLINE]
12.

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.

Johannsson G, Mårin P, Lönn L, Ottosson M, Stenlöf K, Björntorp P, Sjöström L, Bengtsson BA.

J Clin Endocrinol Metab. 1997 Mar;82(3):727-34.

PMID:
9062473
[PubMed - indexed for MEDLINE]
13.

Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.

Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, Villois P, Durazzo M, Cavallo-Perin P, Cassader M.

Curr Med Chem. 2013;20(10):1323-31.

PMID:
23298135
[PubMed - indexed for MEDLINE]
14.

Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome.

Risérus U, Arner P, Brismar K, Vessby B.

Diabetes Care. 2002 Sep;25(9):1516-21.

PMID:
12196420
[PubMed - indexed for MEDLINE]
15.

Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin.

Sneddon AA, Tsofliou F, Fyfe CL, Matheson I, Jackson DM, Horgan G, Winzell MS, Wahle KW, Ahren B, Williams LM.

Obesity (Silver Spring). 2008 May;16(5):1019-24. doi: 10.1038/oby.2008.41. Epub 2008 Mar 6.

PMID:
18356842
[PubMed - indexed for MEDLINE]
16.

Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial.

Georg Jensen M, Kristensen M, Astrup A.

Am J Clin Nutr. 2012 Jul;96(1):5-13. doi: 10.3945/ajcn.111.025312. Epub 2012 May 30.

PMID:
22648709
[PubMed - indexed for MEDLINE]
Free Article
17.

Resveratrol in metabolic health: an overview of the current evidence and perspectives.

Poulsen MM, Jørgensen JO, Jessen N, Richelsen B, Pedersen SB.

Ann N Y Acad Sci. 2013 Jul;1290:74-82. doi: 10.1111/nyas.12141. Review.

PMID:
23855468
[PubMed - indexed for MEDLINE]
18.

Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation.

Duska F, Fric M, Waldauf P, Pazout J, Andel M, Mokrejs P, Tůma P, Pachl J.

Crit Care Med. 2008 Jun;36(6):1707-13. doi: 10.1097/CCM.0b013e318174d499.

PMID:
18496372
[PubMed - indexed for MEDLINE]
19.

A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.

Nagpal J, Pande JN, Bhartia A.

Diabet Med. 2009 Jan;26(1):19-27. doi: 10.1111/j.1464-5491.2008.02636.x.

PMID:
19125756
[PubMed - indexed for MEDLINE]
20.

Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.

Weyer C, Tataranni PA, Snitker S, Danforth E Jr, Ravussin E.

Diabetes. 1998 Oct;47(10):1555-61.

PMID:
9753292
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk